Wells Fargo & Company Forecasts Strong Price Appreciation for American Well (NYSE:AMWL) Stock

American Well (NYSE:AMWL) had its price target hoisted by Wells Fargo & Company from $16.00 to $18.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price would indicate a potential upside of 31.49% from the stock’s current price.

Other equities analysts also recently issued reports about the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of American Well in a report on Thursday, October 15th. Truist Financial set a $12.00 target price on shares of American Well and gave the company a “hold” rating in a research report on Thursday, August 13th. Stifel Nicolaus boosted their target price on shares of American Well from $11.00 to $12.00 and gave the stock a “hold” rating in a research note on Wednesday. Finally, Needham & Company LLC restated a “hold” rating on shares of American Well in a research report on Wednesday, August 5th. One analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, American Well has an average rating of “Hold” and an average price target of $11.30.

American Well Stock Performance

Shares of NYSE:AMWL traded up $0.95 during midday trading on Wednesday, reaching $13.69. 65,267 shares of the company’s stock traded hands, compared to its average volume of 100,865. American Well has a 1 year low of $3.71 and a 1 year high of $15.16. The company has a market cap of $226.55 million, a P/E ratio of -2.84 and a beta of 1.72. The company has a fifty day simple moving average of $12.95 and a two-hundred day simple moving average of $8.99.

American Well (NYSE:AMWL) last released its quarterly earnings results on Tuesday, November 3rd. The company reported ($0.67) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.78) by $0.11. The firm had revenue of $48.99 million for the quarter, compared to analysts’ expectations of $47.28 million. American Well had a negative net margin of 35.75% and a negative return on equity of 30.12%. As a group, research analysts forecast that American Well will post -2.56 EPS for the current fiscal year.

Insider Buying and Selling at American Well

In related news, insider Dmitry Zamansky sold 8,442 shares of the stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $13.00, for a total value of $109,746.00. Following the completion of the transaction, the insider directly owned 224,178 shares of the company’s stock, valued at approximately $2,914,314. This represents a 3.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Phyllis Gotlib sold 6,677 shares of the firm’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $13.00, for a total value of $86,801.00. Following the completion of the transaction, the insider owned 142,504 shares in the company, valued at $1,852,552. The trade was a 4.48% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 19,457 shares of company stock valued at $248,519. 12.84% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On American Well

A hedge fund recently raised its stake in American Well stock. Senvest Management LLC increased its holdings in shares of American Well Corporation (NYSE:AMWL) by 213.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,136,558 shares of the company’s stock after acquiring an additional 773,834 shares during the quarter. Senvest Management LLC owned about 6.87% of American Well worth $5,978,000 at the end of the most recent reporting period. Institutional investors own 56.05% of the company’s stock.

Trending Headlines about American Well

Here are the key news stories impacting American Well this week:

• Positive Sentiment: Third-quarter revenue was $48.99 million, above the cited $47.28 million estimate. The loss of $0.67 per share also narrowed from $1.74 a year earlier, and beat the $0.78 loss estimate cited by MarketBeat. Amwell Q3 2026 results
• Neutral Sentiment: Stifel Nicolaus lifted its price target from $11 to $12 but kept a Hold rating. The higher target is a modest positive, though it was still about 9.3% below the $13.24 share price referenced in the report. Stifel Nicolaus rating information
• Negative Sentiment: Consensus comparisons varied: Zacks said the $0.67 quarterly loss per share was slightly wider than its $0.66 estimate. The company also remains loss-making, a continuing risk for investors. Zacks Q3 earnings coverage

About American Well

American Well, doing business as Amwell, is a digital healthcare company that provides technology and services for virtual care. Its platform connects patients with healthcare professionals through video and other digital channels, supporting services such as urgent care, behavioral health, primary care and specialty consultations.

Amwell primarily serves health systems, health plans, employers and other healthcare organizations. Its offerings include the Amwell Converge platform, which is designed to help organizations develop, manage and integrate digital care programs with existing clinical workflows and healthcare systems.

Founded in 2006 by brothers Ido and Roy Schoenberg, the company was formerly known as American Well and adopted the Amwell brand in 2020.